Search the web
Welcome, Guest
[Sign Out, My Account]

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
CSBR > SEC Filings for CSBR > Form 8-K on 12-Dec-2013All Recent SEC Filings

Show all filings for CHAMPIONS ONCOLOGY, INC.



Entry into a Material Definitive Agreement

Item 1.01. Entry into a Material Definitive Agreement.

On December 6, 2013, Champions Oncology, Inc. (the "Company") entered into a licensing agreement (the "Agreement") with Pfizer Inc. ("Pfizer"), pursuant to which the Pfizer acquired a license to utilize a portion of the Company's TumorGraft technology platform for its studies. In addition, the Company and Pfizer will seek opportunities for further platform development and research collaboration. In consideration for the license, Pfizer will pay an aggregate payment $1,875,000, of which $937,500 is due upon execution of the Agreement and the remaining $937,500 will be paid upon successful delivery.

The foregoing description is a summary only and is qualified in its entirety by reference to the Agreement, which will be filed as an exhibit to the Company's Form 10-Q for the period ending January 31, 2014.

  Add CSBR to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for CSBR - All Recent SEC Filings
Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.